Lead site manufacturing operations and digital transformation for OmniaBio's cell and gene therapy facility; oversee P&L, compliance, engineering, quality, and automation.

OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022.
OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing.
OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.
Browse and apply for open jobs at OmniaBio.
Lead site manufacturing operations and digital transformation for OmniaBio's cell and gene therapy facility; oversee P&L, compliance, engineering, quality, and automation.